menu
    • menu

    Company profile for Rezolute

    NEW Drugs in Dev: 3
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Rezolute is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with metabolic and orphan diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RezoluteUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    201 Redwood Shores Pkwy. Ste. 315 Redwood City, California 94065
    Telephone
    Telephone
    +1 (650) 206-4507
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rezolutebio.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/rezolute
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/rezolutebio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rezolute Unveils Q2 Fiscal 2026 Financials & Business Update
    Rezolute Unveils Q2 Fiscal 2026 Financials & Business Update

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237662/0/en/Rezolute-Reports-Second-Quarter-Fiscal-2026-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    Rezolute To Join Guggenheim Biotech Summit 2026
    Rezolute To Join Guggenheim Biotech Summit 2026

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3231889/0/en/Rezolute-to-Participate-in-the-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    Rezolute Shares sunRIZE Phase 3, EAP Program Insights at CHI
    Rezolute Shares sunRIZE Phase 3, EAP Program Insights at CHI

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214395/0/en/Rezolute-Provides-Insights-from-its-Phase-3-sunRIZE-Study-in-Congenital-Hyperinsulinism-and-Shares-Findings-from-its-Expanded-Access-Program-in-Tumor-Hyperinsulinism.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Rezolute Stock Sinks 87% As Hypoglycemia Drug Fails Ph. 3 Test
    Rezolute Stock Sinks 87% As Hypoglycemia Drug Fails Ph. 3 Test

    12 Dec 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/rezolutes-stock-plunges-87-after-hypoglycemia-drug-flunks-pivotal-phase-3-test

    FIERCE BIOTECH
    12 Dec 2025
    Share Share
    Rezolute Issues Inducement Grant Per Nasdaq LR 5635(C)(4)
    Rezolute Issues Inducement Grant Per Nasdaq LR 5635(C)(4)

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3185129/0/en/Rezolute-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Rezolute Unveils Q1 Fiscal 2026 Financials & Business Update
    Rezolute Unveils Q1 Fiscal 2026 Financials & Business Update

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3183111/0/en/Rezolute-Reports-First-Quarter-Fiscal-2026-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search